Beijing Biostar Pharms Co Overview
Latest PEG ratio for Beijing Biostar Pharms Co: 23.8 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow23.80
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, 2563.HK shows a PEG ratio of 23.8. That is above the Healthcare sector average of 0.46. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 0.46. Beijing Biostar Pharms Co is at 23.8, which is higher that average. That is roughly 5033.8% above the sector mean. Use the comparison chart on this page to see how 2563.HK stacks up against individual peers as well.
Investors watch 2563.HK's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Beijing Biostar Pharms Co's latest reading is 23.8. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Beijing Biostar Pharms Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 23.8) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 0.46, while 2563.HK is at 23.8. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
